Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format
Jul 23, 2008 -- Interleukin Genetics, Inc. (Amex: ILI), announced the launch of an enhanced test report format and information package for the company's Heart Health Genetic Test. The test is currently marketed under the brand name Gensona(R) Heart Health Genetic Test by Quixtar/Amway. The new report will include quantified risk information on heart attack and coronary artery disease generated from clinical studies and conducted by the company.
|
Amarin Proceeding To Phase 3 With AMR101 For Hypertriglyceridemia
Jul 23, 2008 -- Amarin Corporation plc (NASDAQ: AMRN) announced that the Company recently met with officials at the U.S. Food and Drug Administration (FDA) to discuss the Company's plans to develop AMR101 for the treatment of hypertriglyceridemia. Following these discussions, the Company is proceeding to Phase 3 with AMR101 in hypertriglyceridemia. Dr.
|
Heart Disease Is Linked To Worse Mental Processes That, In Turn, Predict The Onset Of Dementia
Jul 23, 2008 -- Coronary heart disease is associated with a worse performance in mental processes such as reasoning, vocabulary and verbal fluency, according to a study of 5837 middle-aged Whitehall civil servants. The study also found that the longer ago the heart disease had been diagnosed, the worse was the person's cognitive performance and this effect was particularly marked in men.
|
Study Finds Link Between Small Birth Size And Changes To The Cardiovascular System That Predispose To Disease In Later Life
Jul 23, 2008 -- Researchers have found the first evidence that smaller size at birth is associated with specific alterations in the functioning of the heart and circulation in children and that these changes differ between boys and girls.
|
Cincinnati Sub-Zero Medical And The Sudden Cardiac Arrest Association Unite To Address Cardiac Arrest
Jul 23, 2008 -- Cincinnati Sub-Zero (CSZ) Medical, a division of CSZ Products, Inc. and the leader in the design and development of advanced patient temperature management solutions, today announced its collaborative partnership with the Sudden Cardiac Arrest Association (SCAA). The SCAA is dedicated to preventing the loss of life from sudden cardiac arrest.
|